Both Semaglutide and the drug represent new approaches to treating blood sugar levels, and increasingly, obesity. It is a dual agonist that impacts two hormones involved in blood sugar control: this peptide and GIP. https://minibookmarking.com/story22310738/grasping-tirzepatide-mounjaro-a-detailed-overview